script.reportAU
Register

Disease index

MDS and CMML

Haematology · 2021–2021

1decision
1medicine
1carried consumer input
0individual submissions

Every decision

MedicineMeetingOutcomeConsumer input
decitabine with cedazuridine Treatment of myelodysplastic syndrome (MDS) classified as intermediate-2 or high-risk according to the International Prognostic Scoring System (IPSS) and… Jul 2021 Recommended with restriction input received Leukaemia Foundation

Who spoke

Leukaemia Foundation

Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.